Phase 4 Oesophageal Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have liver cancer (called HCC) and also have high-risk enlarged veins in the esophagus (the tube connecting the throat to the stomach), confirmed by imaging and clinical information, classified as a moderate or severe level using a standard medical grading system (F2 or F3 according to Beppu et al. classification)
Who may not be able to join:
- People younger than 20 years old or older than 90 years old
- People who have previously had bleeding from enlarged veins in the esophagus
- People who have already received treatment for enlarged esophageal veins, such as banding, injection therapy, a procedure to redirect blood flow through the liver (TIPS), or surgery
- People who have taken a type of blood pressure/heart medication called non-selective beta-blockers in the two weeks before joining the trial
- People who have medical conditions that make non-selective beta-blockers unsafe for them, including certain heart rhythm problems, chronic lung disease (COPD), asthma, poorly controlled diabetes, or severe circulation problems in the legs or arms
- People who have other serious end-stage illnesses, such as advanced cancers other than liver cancer, heart failure, or kidney failure
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +886-2-28712121
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Esophageal variceal bleeding
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.